S10 Ep33: Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
May 30, 2024
10:03
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Levy discusses the indication for trastuzumab deruxtecan in HER2+ NSCLC, other ADCs in development, and where the future of ADCs in NSCLC is headed.